Inflammatix

Septest

This company develops point-of-need blood tests for healthcare professionals to rapidly identify infection and inflammation biomarkers in patients.

Presymptom Health

This company develops AI-driven diagnostic tests and software that detect infection and sepsis in patients for use by healthcare providers and clinical labs.

GNOMX Corp

This company develops epigenetic diagnostic tests using artificial intelligence to identify infectious diseases and predict sepsis readmission risk for healthcare providers and clinicians.

Novus Diagnostic

Novus Diagnostics develops point-of-care diagnostic devices for clinicians to detect and classify bloodstream infections, specifically sepsis, within fifteen minutes at the bedside.

Abionic

This company develops nanofluidic point-of-care diagnostic platforms and blood tests for healthcare professionals to enable rapid detection of sepsis, allergies and iron deficiencies.

CytoVale

This medical diagnostics company develops the IntelliSep test to provide rapid sepsis detection for hospital emergency departments and health systems.

StatDx

This company develops point-of-care molecular diagnostic systems for healthcare providers to identify infectious diseases and critical care conditions.

SepsiScan

This company develops bedside imaging devices for real-time microcirculation monitoring and early sepsis diagnosis for intensive care units and hospitals.